In 2023, the U.S. Food and Drug Administration approved Sifovri, the first treatment for advanced dry age-related macular degeneration, also known as geographic atrophy. The medication is delivered ...

Dry age-related macular degeneration is the most common type — it happens when small deposits form under the retina, causing ...

Discover the latest breakthroughs in the fight against dry, age-related macular degeneration. Learn about the first approved ...

There are two types of macular degeneration: dry and wet. Dry age-related macular degeneration is the most common type — it ...

Innovent Biologics’ eye disease prospect has matched Bayer and Regeneron’s Eylea in a phase 3 study, teeing up filings for ...

Discover more about how a common diabetes drug can reduce the incidence of intermediate age-related macular degeneration.

Macular degeneration (MD) is characterised by the progressive breakdown of the macula, the portion of the retina responsible for sharp, central vision, leading to visual distortion or loss.

Metformin use in people with diabetes was linked to a significantly lower risk of developing intermediate age-related macular ...

This story is part of a series on the current progression in Regenerative Medicine. This piece is part of a series dedicated to the eye and improvements in restoring vision. In 1999, I defined ...

Major ophthalmic events in the first quarter of 2026 included treatments for presbyopia, age-related macular degeneration ...

Please provide your email address to receive an email when new articles are posted on . The Foundation Fighting Blindness and the Nixon Visions Foundation are working together to launch the Nixon ...

Kale contains lutein, which has benefits for eye health and may lower the risk of macular degeneration. This leafy green also ...